Results 101 to 110 of about 24,084 (145)

Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis. [PDF]

Curr Heart Fail Rep
Jefferson A, Narvekar P, Roehm B, Toto R, Roth L, Grodin JL.   +5 more
europepmc   +1 more source

Multimodal Imaging for Monitoring of Disease Progression in Cardiac Amyloidosis: Advances and Gaps in Evidence. [PDF]

J Cardiovasc Dev Dis
Meier C, Soutodeh R, Gielen S.
europepmc   +1 more source

Systemic light chain cardiac amyloidosis with atrioventricular block. [PDF]

Front Cardiovasc Med
Liao J, Pan X.
europepmc   +1 more source

Extracellular Vesicles in Cardiac Amyloidosis: From Pathogenesis to Clinical Applications. [PDF]

Diagnostics (Basel)
Batikyan A, Brown D, Elahmadi Z, Park JH, Ragupathi A, Lohana P, Zoumpourlis P, Shah P, Vishakha M, Mcintosh M, Kladas M, Gokulnath P, Spanos M.   +12 more
europepmc   +1 more source

Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non-Diabetic Patient With Cardiac Amyloidosis. [PDF]

Clin Case Rep
Hamoud SAS, Harding E.
europepmc   +1 more source

Outcomes of Left Atrial Appendage Occlusion in Patients With Cardiac Amyloidosis. [PDF]

Struct Heart
Kshatri S, Lewandowski D, Luo J, Shalmani MA, Berger M, Garg J, Mohananey D.   +6 more
europepmc   +1 more source

Cardiac Amyloidosis: Tribulations and New Frontiers. [PDF]

J Pers Med
Nguyen DM, Ramazani N, Sodhi G, Tak T.
europepmc   +1 more source

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study. [PDF]

Front Cardiovasc Med
Katarzyna G, Ewa D, Mateusz W, Agnieszka S, Natalia P, Katarzyna H, Sylwia WŚ, Wojciech S, Magdalena K, Paweł R.   +9 more
europepmc   +1 more source

Rare case of young cardiac amyloidosis: difficult diagnostic pathway in routine clinical care. [PDF]

Eur Heart J Case Rep
Chumakova OS, Dankovtseva EN, Sannikova MA, Mershina EA, Alexandrova SA, Stepanova EA, Suvorina MY, Zateyshchikov DA.   +7 more
europepmc   +1 more source

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis. [PDF]

Eur J Clin Invest
Kronberger C, Mascherbauer K, Poledniczek M, Schmid LM, Donà C, Koschutnik M, Lunzer L, Rettl R, Duca F, Binder C, Nitsche C, Ermolaev N, Celebi G, Dannenberg V, Beitzke D, Badr Eslam R, Bergler-Klein J, Mascherbauer J, Kastner J, Hengstenberg C, Kammerlander AA.   +20 more
europepmc   +1 more source